Jersey Shore University Medical Center welcomes new director of hepatobiliary surgery

Dr. Gregory Tiesi specializes in treating pancreas, liver, upper gastrointestinal and other related cancers

Hackensack Meridian Jersey Shore University Medical Center recently welcomed Dr. Gregory Tiesi, as medical director of hepatobiliary surgery.

Tiesi is board certified in complex general surgical oncology and general surgery and has specialized in surgical oncology for nearly a decade. He focuses on treating pancreas, liver, upper gastrointestinal, thyroid and other related cancers.

“Dr. Tiesi comes to Jersey Shore with a diverse surgical oncology practice and research that also includes treatment of melanoma, sarcoma, peritoneal and neuroendocrine tumors,” thoracic surgeon Dr. Thomas L. Bauer II, chair of surgery and chief of thoracic surgery at Jersey Shore University Medical Center, said.

Hepatobiliary refers to the liver, gallbladder, pancreas and bile ducts. Tiesi also maintains a very active high volume practice in endocrine and head and neck diseases such as thyroid, parathyroid and adrenal diseases/cancers. Prior to joining Jersey Shore University Medical Center’s oncology team, Tiesi practiced at the Christiana Care Health System/Helen F. Graham Cancer Center in Newark, Delaware, a tertiary referral center for the entire state.

Tiesi completed a general surgery residency at Rutgers-New Jersey Medical School and a research fellowship focused on peritoneal malignancies/hyperthermic intraperitoneal chemotherapy. He received his fellowship training in complex general surgical oncology at the University of Miami. He also holds a fellowship from the American College of Surgeons in addition to the Society of Surgical Oncology. Tiesi was a clinical instructor at the Sidney Kimmel Medical College, part of the Thomas Jefferson University and clinical assistant professor at the Philadelphia College of Osteopathic Medicine.